Immuno-oncology
Product
Indication
Discovery
PCC
IND-enabling
Phase I
Phase II/III
CAN1012
Solid tumors
US & China
CAN1012, PD-1 combo
Solid tumors
China
DVP-001 in partnership with
NSCLC Breast HNSCC
US & China
Small Molecule Drug Conjugate
Product
Indication
Discovery
PCC
IND-enabling
Phase I
Phase II/III
CAN2109
Solid tumors
CAN1100
Solid tumors
CAN1300
Solid tumors
ADC
Product
Indication
Discovery
PCC
IND-enabling
Phase I
Phase II/III
TLR ADC
Tumors
StarLinker
Tumor or autoimmune
Novel Target
Solid tumors
Vaccine Adjuvant - External Collaboration
Product
Indication
Discovery
PCC
IND-enabling
Phase I
Phase II/III
CAN1012
COVID-19, HIV, Shingles